S-Biomedic Company

S-Biomedic brings novel therapeutic solutions to the skin microbiome.The skin microbiome - a habitat of billions of beneficial and harmful bacteria - contributes to healthy skin. An imbalance of these bacteria can lead to a variety of skin conditions including acne, eczema, rosacea and ageing. S-Biomedic uses a targeted modulation-based technology to modify the skin microbiome. This technology can be applied in both the dermatology and cosmetic industries. They design their products using the latest advances in microbiology and dermatology. Using their technology, beneficial bacteria are selected and combined to generate products that accelerate the rebalancing of a disease microbiome. In this way, they are able to restore a healthy state back to your skin.

Connections from

Technology: Skin Microbiome
Industry: Biotechnology
Headquarters: Belgium, United States
Founded Date: 01.01.2014
Employees Number: 01-10
Funding Status: Early Stage Venture
Investors Number: 4
Total Funding: 4 658 210
Estimated Revenue: Less than $1M
Last Funding Date: 18.07.2018
Last Funding Type: Series A

Visit Website
Register and Claim Ownership